目录:MedChemExpress LLC>>同位素标记物>> MMAF-d8 hydrochloride | MCE
纯度 | 99.70% | 分子量 | 776.47 |
---|---|---|---|
分子式 | C₃₉H₅₈D₈ClN₅O₈ | 供货周期 | 现货 |
货号 | HY-15579AS | 应用领域 | 医疗卫生,化工,生物产业,制药/生物制药 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
产品活性:MMAF-d8 (hydrochloride)e是MMAF hydrochloride的氘代形式。
研究领域:Cytoskeleton | Cell Cycle/DNA Damage | Antibody-drug Conjugate/ADC Related
作用靶点:Microtubule/Tubulin | ADC Cytotoxin
In Vitro: MMAF shows in vitro cytotoxicity against a panel of cell lines. The IC50 values for Karpas 299, H3396, 786-O and Caki-1 are 119, 105, 257, and 200 nM, respectively. Targeted MMAF is much more potent than the free drug, and that cAC10 conjugates of MMAF display pronounced activities. On a molar basis, the cAC10-L1-MMAF4 is an average of over 2200-fold more potent than free MMAF and is active on all the CD30-positive cell lines tested.
In Vivo: The maximum tolerated dose in mice of MMAF (>16 mg/kg) is much higher than MMAE (1 mg/kg). cAC10-L1-MMAF4 has an MTD of 50 mg/kg in mice and 15 mg/kg in rats. The corresponding cAC10-L4-MMAF4 ADC was much less toxic, having MTDs in mice and rats of >150 mg/ kg and 90 mg/kg in rats, respectively.
相关产品:Tirbanibulin dihydrochloride | Tubulysin IM-3 | AMXI-5001 hydrochloride | Tubulin polymerization-IN-21 | Dolastatin 10 | (+)-CBI-CDPI1 | SB-216 | MAP4343 | Duocarmycin GA | Tubulin polymerization-IN-8 | Tubulysin IM-1 | Maytansinoid B | Colchicine-d3 | 2-Methoxyestradiol-13C,d3 | Taltobulin | Albendazole | Duocarmycin DM free base | Dideoxy-amanitin | Tilavonemab | DM4-d6 | Camptothecin | EGFR-IN-57 | Epothilone B | Epothilone A | Maytansinol | Maytansinoid DM4 | Docetaxel-d9 | N-Me-L-Ala-maytansinol | Duocarmycin A | Verubulin hydrochloride
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种*仅有化合物库,我们致力于为*科研客户提供前沿的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药 Patent 收录了MCE客户的科研成果;
• 专业团队跟踪新的制药及生命科学研究进展,为您提供*新的活性化合物;
• 与世界各大制药公司及*科研机构建立了长期的合作。